1,803 Shares in Intuitive Surgical, Inc. $ISRG Acquired by Harrell Investment Partners LLC

Key Points

• Harrell Investment Partners LLC acquired 1,803 shares of Intuitive Surgical, Inc., valued at approximately $980,000, indicating potential interest from institutional investors in the medical equipment provider.
• Analyst ratings show a positive outlook, with target prices for Intuitive Surgical raised, including UBS Group's increase to $585.00 and Truist Financial's to $600.00, while the stock maintains an average rating of Moderate Buy.
• Insider sales have occurred, with CEO Gary S. Guthart selling 29,360 shares, a significant decrease of 59.69% in his position, which raises concerns about insider confidence in the company.

Harrell Investment Partners LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,803 shares of the medical equipment provider's stock, valued at approximately $980,000.

A number of other large investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock worth $16,178,258,000 after buying an additional 453,335 shares in the last quarter. Invesco Ltd. boosted its holdings in shares of Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider's stock valued at $2,090,027,000 after purchasing an additional 71,794 shares in the last quarter. Northern Trust Corp boosted its holdings in shares of Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider's stock valued at $1,798,465,000 after purchasing an additional 11,988 shares in the last quarter. Wellington Management Group LLP boosted its holdings in shares of Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after purchasing an additional 457,080 shares in the last quarter. Finally, Nuveen LLC acquired a new stake in shares of Intuitive Surgical in the 1st quarter valued at $1,715,899,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on ISRG shares. UBS Group raised their target price on Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. Truist Financial raised their target price on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Wells Fargo & Company raised their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Finally, Zacks Research downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Thirteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $595.95.

Insiders Place Their Bets

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider directly owned 19,827 shares of the company's stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director directly owned 1,074 shares in the company, valued at $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $443.99 on Thursday. The firm has a market cap of $159.16 billion, a PE ratio of 61.92, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61. The firm's fifty day moving average is $472.54 and its 200-day moving average is $502.13. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical's revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.78 earnings per share. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.